Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Non-cash Items (2019 - 2025)

Historic Non-cash Items for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $108.4 million.

  • IDEAYA Biosciences' Non-cash Items rose 1186.79% to $108.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.4 million, marking a year-over-year increase of 1186.79%. This contributed to the annual value of $90.2 million for FY2024, which is 11946.47% up from last year.
  • According to the latest figures from Q3 2025, IDEAYA Biosciences' Non-cash Items is $108.4 million, which was up 1186.79% from $118.8 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Non-cash Items registered a high of $118.8 million during Q2 2025, and its lowest value of $41400.0 during Q4 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Non-cash Items value was $46.8 million (recorded in 2023), while the average stood at $58.4 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Non-cash Items surged by 6753285.02% in 2022 and then skyrocketed by 935.73% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Non-cash Items (Quarter) stood at $41400.0 in 2021, then skyrocketed by 67532.85% to $28.0 million in 2022, then soared by 46.79% to $41.1 million in 2023, then surged by 119.46% to $90.2 million in 2024, then increased by 20.18% to $108.4 million in 2025.
  • Its Non-cash Items stands at $108.4 million for Q3 2025, versus $118.8 million for Q2 2025 and $115.7 million for Q1 2025.